What does this research mean for the field?

Radiofrequency ablation is a safe and effective treatment for benign thyroid nodules in patients with implantable cardiac devices, provided appropriate monitoring is used. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

March 3, 2026Open Access

Safety and efficacy of radiofrequency ablation of benign thyroid nodules in patients with a history of implantable cardioverter defibrillators (ICDs), permanent pacemakers (PPMs), and implantable cardiac monitors (ICMs)

Key Points

Radiofrequency ablation shows efficacy in treating benign thyroid nodules in patients with a history of ICDs, ICMs, and PPMs.
Safety was confirmed through appropriate monitoring during the procedure, ensuring minimal risk to the patients.

Structured PICO

Is radiofrequency ablation safe and effective for treating benign thyroid nodules in patients with implantable cardiac devices?

Population

Patients with benign thyroid nodules and a history of implantable cardioverter defibrillators (ICDs), permanent pacemakers (PPMs), and implantable cardiac monitors (ICMs)

Intervention

Radiofrequency ablation (RFA)

Outcome

Safety and efficacysafety

Radiofrequency ablation of benign thyroid nodules appears safe and effective in patients with implantable cardiac devices when appropriate monitoring is utilized.

Abstract

RFA appears to be a safe and effective treatment for benign thyroid nodules in patients with a history of ICDs, ICMs, and PPMs. Our experience demonstrated the safety of RFA and supported its utility in this high-risk population when performing these procedures with appropriate monitoring.

Safety and efficacy of radiofrequency ablation of benign thyroid nodules in patients with a history of implantable cardioverter defibrillators (ICDs), permanent pacemakers (PPMs), and implantable cardiac monitors (ICMs)

Key Points

Structured PICO

Abstract

Cite This Study